Диссертация (1140852), страница 30
Текст из файла (страница 30)
– 2003. - #74(1). – P. 5-13.178• King, C. Treatment of sarcoidosis / C. King, W. Kelly // Disease a month.2009. - №55. – P. 704-718.• Kleijn, W. Nature of fatigue moderates depressive symptoms and anxiety insarcoidosis / W. Kleijn, M. Drent, J. De Vries // British J. health Psychology.-2013. - №9. – P. 1-14.• Kleijn, W. Types of fatigue in sarcoidosis patients / W.
Kleijn, M. Drent, J.Vermunt et al. // J.Psychosom.Res. – 2011. - №71. – P. 416-422.http://dx.doi.org/ HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006" HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006" HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006"10.1016 HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006" HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006" HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006"/j.jpsychores.HYPERLINK "http://dx.doi.org/10.1016/j.jpsychores.2011.09.006"HYPERLINK "http://dx.doi.org/10.1016/j.jpsychores.2011.09.006"HYPERLINK"http://dx.doi.org/10.1016/j.jpsychores.2011.09.006"2011.09.006•Kleist, К.
Die Influenzapsychosen und die Anlage zu Infektionpsychosen /R. Kleist. - Berlin: Verlag von Julius Springer, 1920. – 54 S.• Klonoff, E. Psychological factors in sarcoidosis: The relationship betweenlife stress and pulmonary function / E. Klonoff, M. Kleinhenz // Sarcoidosis.- 1993. - №10. – P. 118-124.• Korenromp, I. Post-inflammatory fatigue in sarcoidosis: personality profiles,psychological symptoms and stress hormones / I. Korenromp, J. Grutters, J.van den Bosch et al. // J. Psychosom.Res.
– 2012. - №72. – P. 97-102.179• Korenromp, I.Characterization of chronic fatigue in patients with sarcoidosisin clinical remission / I. Korenromp, C. Heijen, O. Vogels // Diffuse Lungdis. – 2011. - №140(2). – P. 441-447.•Lange C. Psychosomatische Aspekte bei der Sarkoidose. [dissertation]Leipzig: 1991. – 128 s.• Lange, C. Psychosomatic aspects of sarcoidosis / C. Lange, G. Schussler, U.Huttemann // Pneumologie. – 1995.
- №49(1). – P. 14-9.•Laplante, E. The selective attention deficit in schizophrenia: limitedresourses or cognitive fatigue? / E. Laplante, T. Jacques // Journal ofnervous and mental disease. - 1989. - №177(12). – P. 37-52• Lasebikan, V. Prevalence of psychosis in tuberculosis patients and theirnontuberculosis family contacts in a multidrug treatment-resistant treatmentcenter in Nigeria / V. Lasebikan // General Hospital Psychiatry. – 2015. №37(6).
– P. 542-547.• Ligon, C. Impact of systemic corticosteroids on healthcare utilization inpatients with sarcoidosis / C. Ligon, M. Judson // Am J Med Sci. -2011. №341(3). – P. 196-201.• Ling, M. Side effects of corticosteroid therapy: psychiatric aspects / M.Ling, P. Perry, M. Tsuang // Arch Gen Psychiatry. – 1981. - №38(4). – P.471-477.• Liu, S. The Prevalence of Anxiety and Depression in Chinese AsthmaPatients / S. Liu, R. Wu, L.
Li et al. // Plos one. – 2014. - №9(7). – P. 1-7.• Lu, Y. Life event stress and chronic obstructive pulmonary disease (COPD):associations with mental well-being and quality of life in a population-based180study / Y. Lu, M. Nyunt, X. Gwee et al. // BMJ Open. – 2012. – №19. – P.2-6.• Lynch, J.
Extrapulmonary sarcoidosis / J. Lynch, O. Sharma, R. Baughman// Semin Respir Infect. – 1998. - №13(3). – P.229-54.• Macleod, T. Neutrophil Elastase-mediated proteolysis activates the antiinflammatory cytokine IL-36 Receptor antagonist / T. Macleod, R. Doble,D. Macgonagle // Sci Rep. – 2016. – 6.
– P. 248-280.• Marcellis, R. Association between physical functions and quality of life insarcoidosis / R. Marcellis, A. Lenssen, M. Drent // Sarcoidosis vasculitis anddiffuse lung diseases. – 2014. - №31. – P. 117-128• Mathews, A. Cognitive vulnerability to emotional disorders / A. Mathews,C. Macleod // Annu. Rev. Clin. Psychol. – 2005. - №1. – P. 167-195.• Michielsen, H. Fatigue is associated with quality of life in sarcoidosispatients / H. Michielsen, M. Drent, T. Peros-Golubicic et al.
// Chest. 2006. №130(4). – P. 989-94.•Mlczoch, F. Clinical findings of sarcoidosis. Report on 250 cases / F.Mlczoch, J. Kohut // Wien Klin Wochenschr. – 1970. - №82(13). – P. 22934.• Muramatsu, Y. Bronchial asthma: psychosomatic aspect / Y. Muramatsu, K.Muramatsu, I. Mashima et al. // JMAJ. – 2003. - №46(5). – P. 204–207.•Nguyen, N. Efficacy of etifoxine compared to lorazepam monotherapy in thetreatment of patients with adjustment disorders with anxiety: a double-blindcontrolled study in general practice / N. Nguyen, E.
Fakra, V. Pradel // HumPsychopharmacol. – 2006. - №21(3). – P. 139–49.181• Pachi, A. Bratis D, Moussas G, Tselebis A. Psychiatric Morbidity and OtherFactors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients/ A. Pachi, D. Bratis, G. Moussas // Tuberculos Res Treatment. – 2013. №1. – P. 48–98.• Rajesh, T.
Temperamental traits and psychological problems of childrenwith bronchial asthma / T. Rajesh, P. Krishnakumar, L. Mathews // IndianPediatr. – 2008. - №45(9). – P. 772-4.• Rozsa, C. Myasthenia in a patient with sarcoidosis and schizophrenia / C.Rozsa, G. Kis, S. Komoly // Ideggyogy Sz. – 2004. - №20. – P. 242-4.• Ryder, A. The overlap of depressive personality disorder & dysthymia / A.Ryder, M. Bahby, D. Schuller // Harvard Rev Psychiatry. – 2002. - №10. –P. 337-352.• Scano, G. Dyspnea and emotional states in health and disease / G.
Scano, L.Stendardi, F. Gigliotti // Respiratory medicine. – 2013. - №107(5). – P. 64955.• Schneider, C. COPD and the risk of depression / C. Schneider, S. Jick, U.Bothner // Chest. – 2010. - №137(2). – P. 341-7.• Schneider, K. Die Psychopathischen Personlichkeiten / K. Schneider. –Vienna: Deuticke, 1928. – Leipzig; Wien, 1928. – 327 s.• Schüssler, G. Multi-axial diagnosis in psychosomatic medicine andpsychotherapy--a report of experiences / G. Schussler, G.
Leibing, U. Ruger// Z Psychosom Med Psychoanal. – 1990. - №36(4). – P. 343-54.• Sharma, O. Fatigue and sarcoidosis / O. Sharma // Eur Respir J. -1999. –№13. – P. 713–714.182• Sharma, O. Neurosarcoidosis: a personal perspective based on the study of37 patients / O. Sharma // Chest. – 1997. - №112(1). – P. 220-8.• Sharma, O.
Vitamin D, calcium, and sarcoidosis / O. Sharma // Chest. –1996. - №109(2). – P. 535-9.• Skodol, A. Personality disorder types pro- posed for DSM-5 / A. Skodol, D.Bemder, L. Morey et al. // J Pers Disord. - 2011. -№25. – P. 136-169.• Smets, E. The Multidimensional Fatigue Inventory (MFI) psychometricqualities of an instrument to assess fatigue / E. Smeths, B. Garssen, B.Bonke et al. // J Psychosom Res.
- 1995. - №39(3). – P. 315–25.• Spruit, M. Thomeer M, Gosselink R. Skeletal muscle weakness in patientswith sarcoidosis and its relationship with exercise intolerance and reducedhealth status / M. Spruit, M. Thomeer, R. Gosselink // Thorax. – 2005. №60. – P. 32–38.•Studt, H. Die Sarkoidose in psychosomatischer Sicht / H. Studt, H. Haensel,H. Reiber. Deutschen psychoanalytischen Gesellschaft, 1981. – 47 s.• Swigris, J. Sarcoidosis-related mortality in the United States from 1988 to2007 / J. Swigris, A.
Olson, T. Huie et al. // Am J Respir Crit Care Med.2011. - №183(11). – P. 1524-30.• Tedeschi, R.G. The posttraumatic Growth Inventory: Measuring the positivelegacy of trauma / R. G. Tedesci, L. G. Calhoun//J. of traumatic stress. –1996. - No9(3). – P. 455-471.• Trombini, G. Sarcoidosis: Psychotherapy and Long-Term Outcome—ACase Report / G. Trombini, E. Trombini // Case Reports in Medicine. 2012. №1. – P. 1-4183• van Helmondt, S. Literature review on depressive symptoms in patients withsarcoidosis [dissertation]. Tilburg University; 2010 – 27 p.• Victorson, D.
Quality of life evaluation in sarcoidosis: current status andfuture directions / D. Victorson, D. Cella, M. Judson // Curr Opin PulmMed. – 2008. - №14(5). – P. 470-7.• Vögele, C. von Leupoldt A. Mental disorders in chronic obstructivepulmonary disease (COPD) / C. Vogele, A. von Leupoldt // Respir Med. –2008. - №102(5). – P.
764-73.• Vučinić, V. Fatigue in Sarcoidosis: Detection and Treatment / V. Vucinic,M. Stojkovic, B. Milenkovic et al. // Srp Arh Celok Lek. – 2012. - 140(1-2).– P. 104-110• Waters, F. Naik N, Rock D. Sleep, fatigue, and functional health inpsychotic patients / F. Waters, N. Naik, D. Rock // Schizophr Res Treatment.-2013. - №2013.
– P. 42-58.• Wilsher, M. Psychological stress in sarcoidosis / M. Wilsner // Curr OpinPulm Med. – 2012. - №18(5). – P. 524-7.• Wirnsberger, R. De Vries J, Wouters E. Clinical presentation of sarcoidosisin The Netherlands: an epidemiological study / R. Wirnsberger, J. De Vries,E. Wouters // Neth J Med. – 1998. - №53. – P. 53–60.• Wirnsberger, R. Impairment of quality of life: rheumatoid arthritis versussarcoidosis / R.
Wirnsberger, J. De Vries, T. Jansen et al. // Neth J Med. 1999. - №54. – P. 86–95.• Wolfe, F. The American College of Rheumatology Preliminary DiagnosticCriteria for Fibromyalgia and Measurement of Symptom Severity / F.Wolfe, B. Clauw, M. Fitzcharles et al. // Arthritis Care & Research. – 2010.– 62(5). – 600-610.184• Wurm, K. The staging theory of sarcoidosis / K. Wurm // Dtsch MedWochenschr. - 1983. - №108(26).
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
